References
- Agency for Healthcare Research and Quality. (2002). Evidence report/technology assessment: Number 47. Systems to rate the strength of scientific evidence (AHRQ Publication No. 02-E015). Retrieved March 09, 2018 from https://archive.ahrq.gov/
- Blattner, C. M., Danesh, M., Safaee, M., & Murase, J. E. (2016). Understanding the new FDA pregnancy and lactation labeling rules. International Journal of Women's Dermatology, 2(1), 5–7. https://doi.org/10.1016/j.ijwd.2015.12.005
- Bookstaver, P. B., Bland, C. M., Griffin, B., Stover, K. R., Eiland, L. S., & McLaughlin, M. (2015). A review of antibiotic use in pregnancy. Pharmacotherapy, 35(11), 1052–1062. https://doi.org/10.1002/phar.1649
- Brouwers, M. C., Kho, M. E., Browman, G. P., Burgers, J. S., Cluzeau, F., Feder, G., Fervers, B., Graham, I. D., Grimshaw, J., Hanna, S. E., Littlejohns, P., Makarski, J., Zitzelsberger, L., & for the AGREE Next Steps Consortium. (2010). AGREE II: Advancing guideline development, reporting and evaluation in health care. Canadian Medical Association Journal = Journal de L'association Medicale Canadienne, 182(18), E839–E842. https://doi.org/10.1503/cmaj.090449
- Centers for Disease Control. (2015a). Bacterial vaginosis. Retrieved March 09, 2018, from https://www.cdc.gov/
- Centers for Disease Control. (2015b). 2015 Sexually transmitted diseases treatment guidelines. Retrieved March 11, 2018, from https://www.cdc.gov/std/tg2015/bv.htm
- Centers for Disease Control. (2017). Medications and pregnancy. Retrieved March 09, 2018, from https://www.cdc.gov/pregnancy/meds/index.html
- Cram, L. F., Zapata, M., Toy, E. C., & Baker, B., III. (2015). Genitourinary infections and their association with preterm labor. American Family Physician, 65(2), 241–249.
- Federal Drug Administration. (2016). Pregnancy and lactation labeling final rule. Retrieved March 11, 2018, from https://www.fda.gov/drugs/labeling-information-drug-products/pregnancy-and-lactation-labeling-drugs-final-rule
- Federal Drug Administration. (2018). Pregnancy categories – CHEMM. Retrieved February 27, 2018, from https://chemm.nlm.nih.gov/pregnancycategories.htm
- Gilbert, N. M., O'Brien, V. P., Hultgren, S., Macones, G., Lewis, W. G., & Lewis, A. L. (2013). Urinary tract infection as a preventable cause of pregnancy complications: Opportunities, challenges, and a global call to action. Global Advances in Health and Medicine, 2(5), 59–69. https://doi.org/10.7453/gahmj.2013.061
- Glasziou, P., Mar, C. D., & Salisbury, J. (2007). Evidence-based practice workbook (2nd ed.) Blackwell.
- Hollier, A. (2016). Clinical guidelines in primary care 2nd edition 2016 by Amelie Hollier (2016-05-04). In Medication use in pregnancy (2nd ed., pp. 581–584). Advanced Practice Education Associates.
- Jena, A. B., Seabury, S., Lakdawalla, D., & Chandra, A. (2011). Malpractice risk according to physician specialty. New England Journal of Medicine, 365(7), 629–636. https://doi.org/10.1056/NEJMsa1012370
- Johnson, M., Hooper, D. C., & Bond, S. (2018, February 1). Metronidazole: An overview. Retrieved March 11, 2018, from https://www.uptodate.com/contents/metronidazole-anoverview
- Lofmark, S., Edlund, C., & Nord, C. (2010). Metronidazole is still the drug of choice for treatment of anaerobic infections. Clinical Infectious Diseases, 50(S1), S16–S23. https://doi.org/10.1086/647939
- Lilley, L. L., Harrington, S., & Snyder, J. S. (2007). Pharmacology and the nursing process (3rd ed.). Elsevier Mosby.
- Melnyk, B. M., & Fineout-Overholt, E. (2015). Critically appraising quantitative evidence for clinical decision making. In Evidence-based practice in nursing and healthcare: A guide to best practice (3rd ed., pp. 87–138). Wolters Kluwer.
- Muanda, F. T., Sheehy, O. A., & Bérard, N. (2017). Use of antibiotics during pregnancy and risk of spontaneous abortion. Canadian Medical Association Journal = Journal de L'association Medicale Canadienne, 189(17), E625–33. https://doi.org/10.1503/cmaj.161020
- Niebyl, J. R., & Simpson, J. (2008). Teratology and drugs in pregnancy. Global Library of Women's Medicine. https://doi.org/10.3843/GLOWM.10096. Sapiens Publishing, LTD.
- Pernia, S., & DeMaagd, G. (2016). The new pregnancy and lactation labeling rule. P & T, 41(11), 713–715. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083079/.
- Sachdeva, P., Patel, B. G., & Patel, B. K. (2009). Drug use in pregnancy; a point to ponder!! Indian Journal of Pharmaceutical Sciences, 71(1), 1–7. https://doi.org/10.4103/0250-474X.51941
- Sheehy, O., Santos, F., Ferreira, E., & Berard, A. (2015). The use of metronidazole during pregnancy: A review of evidence. Current Drug Safety, 10(2), 170–179. https://doi.org/10.2174/157488631002150515124548
- Widnes, S. F., & Schjøtt, J. (2017). Risk perception regarding drug use in pregnancy. American Journal of Obstetrics and Gynecology, 216(4), 375–378. https://doi.org/10.1016/j.ajog.2016.12.007